A5035412390- Reproductive Biology and Fertility
- Ovarian function and disorders
- Assisted Reproductive Technology and Twin Pregnancy
- Reproductive System and Pregnancy
- Endometriosis Research and Treatment
- Ectopic Pregnancy Diagnosis and Management
- Gynecological conditions and treatments
- Prenatal Screening and Diagnostics
- Pregnancy and Medication Impact
- Reproductive Health and Technologies
- Ovarian cancer diagnosis and treatment
- Hormonal and reproductive studies
- Reproductive Health and Contraception
- Estrogen and related hormone effects
- Pluripotent Stem Cells Research
- Uterine Myomas and Treatments
- Sexual Differentiation and Disorders
- Healthcare Systems and Practices
- Endometrial and Cervical Cancer Treatments
- Genomic variations and chromosomal abnormalities
- Antibiotic Use and Resistance
- Tissue Engineering and Regenerative Medicine
- Acute Kidney Injury Research
- Gestational Trophoblastic Disease Studies
- Genetic Syndromes and Imprinting
Université Laval
2025
Université de Montréal
2013-2024
Centre Hospitalier Universitaire de Tours
2024
Boston Medical Center
2024
Alberta Energy
2023
Centre Hospitalier Universitaire Sainte-Justine
2013-2022
Ottawa Fertility Centre
2020
Mario Negri Institute for Pharmacological Research
2015
Hospices Civils de Lyon
2010
Hôpital Femme Mère Enfant
2010
Our aim was to evaluate whether extending the interval between human chorionic gonadotrophin (hCG) priming and immature oocyte retrieval increases maturation rate following in vitro (IVM).This study performed retrospectively. IVM on 113 polycystic ovary syndrome patients (n = 120 cycles). Oocyte collection either 35 h (Group 1; n 76) or 38 2; 44) after 10,000 IU of hCG priming. Following retrieval, maturity assessed remaining oocytes were cultured medium up Day 2.The number vivo matured...
To provide a comprehensive review and evidence-based recommendations for the delivery of fertility care to women with obesity.The impact obesity on fertility, treatments, both short long-term maternal fetal outcomes was carefully considered.Published literature reviewed through searches MEDLINE CINAHL using appropriate vocabulary key words. Results included systematic reviews, clinical trials, observational studies, practice guidelines, expert opinions.The Canadian Fertility & Andrology...
Abstract The effectiveness of intravenous immunoglobulin (IVIg) for patients with unexplained recurrent implantation failure (uRIF) remains debated. We retrospectively analysed outcomes uRIF treated IVIg compared to a separate control cohort within our center (01/2014–12/2021). Primary included live birth, miscarriage, or transfer failure. documented side effects and maternal/fetal outcomes. Logistic regression analysis was used assess association exposure adjust confounders. study 143...
Recurrent pregnancy loss (RPL) affects up to 4% of couples attempting conceive. RPL is unexplained in over 50% cases and no effective treatments exist. Due the immune system's pivotal role during implantation pregnancy, immune-mediated may be suspected immunomodulatory like intravenous immunoglobulin (IVIg) have been administered but remain controversial. The goal our study was evaluate center's 6 year-outcomes develop a framework for IVIg use RPL.Retrospective, single-center cohort study....
Febrile neutropenia (FN) is a serious complication of chemotherapy that often leads to hospitalization in cancer patients. It now well-established carefully selected patients can be safely treated on an outpatient basis. The objective this study was assess the number and proportion hospitalized for FN university hospital setting who would have met low-risk criteria FN, whether these experienced favorable outcomes during hospitalization. We conducted retrospective all admitted at three...
To compare clomiphene citrate (CC) and letrozole for ovarian stimulation (OS) in therapeutic donor sperm insemination (TDI) cycles.Retrospective cohort study between January 2011 June 2014 at a University-affiliated private IVF clinic Montreal, Canada. 257 normo-ovulatory women ≤40 years of age with no history infertility undergoing 590 TDI cycles the absence male partner (single same-sex couples) or azoospermia were included. Patients received 100 mg CC daily (145 women, 321 cycles) 5 (112...